Are U.S. Taxpayers Losers in Foreign M&A Deals?

Are U.S. Taxpayers Losers in Foreign M&A Deals? Play

April 29 (Bloomberg) -- Marshall Sonenshine, chairman at Sonenshine Partners, discusses U.S. corporate tax structure as Pfizer is set to save offshore tax dollars in a proposed deal to purchase AstraZeneca in the U.K. on Bloomberg Television’s “Bloomberg Surveillance.”

  • On Air Now

    Bloomberg Surveillance Watch Now

  • Next

    In The Loop with Betty Liu

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus